Early vascular graft infection due to Yersinia enterocolitica after repair of an abdominal aortic aneurysm.
Abad
C
C
Ponce
G
G
Elcuaz
R
R
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017544:Aortic Aneurysm, Abdominal / Q000601:surgery; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation; D002439:Cefotaxime / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery*; D015009:Yersinia Infections / Q000188:drug therapy / Q000601:surgery*; D015008:Yersinia enterocolitica
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D002439:Cefotaxime